26 June 2020 : Clinical Research
Hepatitis B Surface Antigen (HBsAg) Kinetics in Chronic Hepatitis B Patients during Peginterferon Treatment
Kaifa Wang1AEG, Guangyu Huang2BCF*, Yagang Chen2DF, Yuming Wang34BFDOI: 10.12659/MSM.921487
Med Sci Monit 2020; 26:e921487
Table 5 Distribution of five clusters from 116 uncured patients.
Cluster | Male | Female | Age (years, means±SD) | Baseline HBsAg levels (IU/mL, median (Q1, Q3)) | Length of treatment (days, median (Q1, Q3)) |
---|---|---|---|---|---|
Cluster 1 (n=50) | 41 | 9 | 37.88±7.33 | 721.52 (73.28, 1767.85) | 119.50 (91.00,151.75) |
Cluster 2 (n=6) | 4 | 2 | 37.33±6.19 | 505.40 (25.98, 10134.47) | 153.50 (135.25,178.75) |
Cluster 3 (n=38) | 29 | 9 | 35.87±6.18 | 1714.03 (757.75, 17297.88) | 135.50 (89.50,154.50) |
Cluster 4 (n=15) | 12 | 3 | 35.87±7.91 | 763.51 (222.00, 5425.26) | 77.00 (70.00,150.00) |
Cluster 5 (n=7) | 7 | 0 | 35.29±4.39 | 12097.10 (34.12, 34870.00) | 149.00 (125.00,168.00) |
Total (n=116) | 93 | 23 | 36.78±6.82 | 909.44 (156.91, 5356.35) | 132.00 (90.25,154.00) |